A study of 1,503 adults with type 1 diabetes measured barriers to device uptake (insulin pump and continuous blood glucose monitors (CGM)) and compared the profiles of device users versus nonusers. For the whole sample, from a list of 19, the three most commonly endorsed barriers to diabetes device uptake were ‘cost of supplies’ (61%), ‘cost of device’ (57%) and ‘insurance coverage’ (57%), all of which were deemed to be ‘non-modifiable’ barriers by the authors. The top three commonly endorsed ‘modifiable’ barriers were ‘hassle of wearing devices all of the time’ (47%), ‘do not like having diabetes devices on my body’ (35%) and ‘do not like how diabetes devices look on my body’ (26%).
Read more